IQVIA Launches Avacare Clinical Research Network to Increase Patients’ Clinical and Research Options

By AIT News Desk On Feb 24, 2020

IQVIA, a leader in human data science, announced the launch of Avacare Clinical Research Network™, a technology-based global site network that opens opportunities for more clinical trials at experienced clinical and research sites. Avacare’s unique analytical tools help sites in Avacare’s network match patients to clinical trials faster and more effectively.

“We believe combining clinical research and patient care produces better patient outcomes, reduces cost of care, and advances research that will benefit patients”

“We believe combining clinical research and patient care produces better patient outcomes, reduces cost of care, and advances research that will benefit patients,” said Cynthia Verst, president, Design and Delivery Innovation, Research & Development Solutions at IQVIA. “This is another example of IQVIA’s commitment to human data science, where our Avacare network enables practices to efficiently match trial participants to clinical trials, advancing medical innovation.”

Recommended AI News: 100 Emerging GovTech Startups You Should Know About

Japanese Researchers Release “Fugaku-LLM” Trained on the Fugaku Supercomputer

May 10, 2024

Don’t Underestimate the Name of Your AI Brand

May 9, 2024

Phone.com’s AI-Connect Blends NLP, NLU and LLM to Elevate Calling Experience

May 8, 2024

Prev Next 1 of 40,349

Previously known as Qcare, Avacare has now expanded to include sites in the U.S. and India, with coverage across 19 therapeutic areas. Through existing physician relationships connected to approximately 6.5 million patients globally, Avacare provides innovative treatment options that drive healthcare forward.

Recommended AI News: Top 11 Use Cases of RPA in the Insurance Industry

Avacare uses innovative clinical technology with advanced analytics to deliver artificial intelligence-powered patient referrals and data-driven enrollment trends. By utilizing proprietary algorithms and privacy-protected health records across sites, Avacare precisely identifies the best patients to opt-in for each trial and supports the investigators in engaging patients for those trials.